You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 2, FEBRUARY 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multiple-Dose Charcoal and Whole-Bowel Irrigation Do Not Increase Clearance of Absorbed Salicylate

A. Lisl Mayer; Daniel S. Sitar, PhD; Milton Tenenbein, MD, FRCPC

Arch Intern Med. 1992;152(2):393-396.


Abstract

Background. —
This study assesses whether oral multiple-dose charcoal therapy (MDC) or whole-bowel irrigation (WBI) enhances the excretion of previously absorbed salicylate.

Methods.—
A controlled, randomized, three-limbed crossover protocol was used in nine humans who ingested aspirin. Salicylate levels were measured in serial serum specimens and 32-hour urine collections and kinetic parameters were calculated.

Results.—
There were no differences among the control (CTL), MDC, or WBI groups for area under the serum concentration vs time curve (CTL, 2320±501 mg/L·h MDC, 2040±454 mg/L·h; WBI, 2093±418 mg/L·h) or for urinary salicylates (CTL, 54.9%±9.4%; MDC, 50.9%±8.0%, WBI, 52.4%±13.7% of ingested dose).

Conclusions.—
Our data do not support the use of either MDC or WBI to enhance the excretion of previously absorbed salicylate in poisoned patients. In patients with drug overdoses, a clear rectal effluent remains as the endpoint for WBI.

(Arch Intern Med. 1992;152:393-396)



Author Affiliations

From the Departments of Pharmacology and Therapeutics (Ms Mayer and Drs Sitar and Tenenbein), Pediatrics and Child Health (Dr Tenenbein), and Internal Medicine (Drs Sitar and Tenenbein), University of Manitoba, Winnipeg; and the Manitoba Poison Control Centre (Dr Tenenbein).


Footnotes

Accepted for publication September 20, 1991.

Read before the American Academy of Clinical Toxicology Annual Meeting, Toronto, Ontario, October 2, 1991.

Reprint requests to Children's Hospital, 840 Sherbrook St, Winnipeg, Manitoba, Canada R3A 1S1 (Dr Tenenbein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.